Direct Answer
Wound care companies make dressings, negative-pressure systems, skin substitutes and biologics for chronic and surgical wounds. Sales go to hospitals, clinics and home care, with reimbursement rules deciding which products clinicians use.
Industry Overview
Wound Care sits within the health care sector. The first numbers to compare across companies here are organic growth by product line, gross margin and reimbursement coverage. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Organic growth by product line: Sales growth excluding acquisitions and currency, split among dressings, devices and biologics. It shows which categories are driving demand, as coverage varies widely between them.
- Gross margin: Share of sales left after product cost. Advanced products earn more than basic dressings, so mix and reimbursement changes move margin.
- Reimbursement coverage: Whether Medicare and insurers pay for the product and at what rate. Coverage changes, particularly for skin substitutes, can quickly change what clinicians choose.
- Installed base of devices and consumables: Number of negative-pressure systems in use and the dressings they require. Each placed system drives reorders, so base growth supports recurring revenue.
- Clinical evidence: Trial and real-world data showing healing outcomes. Payers and clinicians increasingly demand it, so stronger evidence supports coverage and price.
Primary Macro Drivers
- Diabetes and aging-related chronic wounds: People with diabetes and older patients are more prone to chronic wounds, which raises the number of patients needing dressings and advanced products.
- Medicare coverage for skin substitutes: Whether Medicare pays for skin substitutes decides if clinics will use them, so coverage changes move sales of those products.
- Hospital surgical volumes: More operations mean more surgical wounds to treat, which supports sales of dressings and negative-pressure systems in hospitals.
- Home health reimbursement: Home health payment rules decide whether agencies use advanced products, which sets volume in that channel.
Major Risks
- Reimbursement changes on advanced wound products: Cuts or tighter rules for advanced products can reduce what clinicians choose to use, lowering sales; watch reimbursement coverage and gross margin.
- Fraud and billing scrutiny: Investigations into billing for expensive products can lead to repayments and demand drops; watch legal proceedings and policy changes.
- Competition from lower-cost dressings: Cheaper basic dressings can replace advanced products when budgets are tight; watch organic growth by product line and gross margin.
- Clinical evidence thresholds: Payers require trial evidence that products speed healing before paying, so weak data can limit coverage; watch clinical evidence releases and coverage updates.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. / Global |
Companies Associated with Wound Care
The SEC's Standard Industrial Classification has no code that describes wound care as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. | Pharmaceutical Preparations | $564 million | 17.0% | 6.6% | FY 2025 |
| Mimedx Group, Inc. | Surgical & Medical Instruments & Apparatus | $419 million | 20.0% | 11.6% | FY 2025 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Wound Care guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Ambulatory Surgery Centers
- Women's Health Pharmaceuticals
- Animal Health
- Veterinary Services
- Antibody Therapeutics
- Vaccines
- Behavioral Health Providers
- Urgent Care
Put it to work
Frequently Asked Questions
What are the main KPIs for the Wound Care industry?
Key performance indicators for the Wound Care industry include: Organic growth by product line, Gross margin, Reimbursement coverage, Installed base of devices and consumables, Clinical evidence. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Wound Care industry?
The Wound Care industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Wound Care industry?
The primary risks for Wound Care companies include: Reimbursement changes on advanced wound products, Fraud and billing scrutiny, Competition from lower-cost dressings, Clinical evidence thresholds. Investors should assess each company's exposure to these factors and its track record of navigating them.